ICUSeaStar Medical Holding Corporation

ICU Stock Price, Valuation & Chart | SeaStar Medical Holding Corporation

Compare

$2.880-0.11 (-3.68%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology ICU intrinsic value ICU calculated fair value vs price

Overview Financials Dividends Ratios

ICU Historical price chart

ICU Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization8.17M

PE Ratio-0.91

EPS-3.18

Trading Volume85.33K

Today's High/Low3.03/2.87

Dividend Yield0.00

52 Week High/Low12.5/2.07

Shares Outstanding2.84M

ICU Financial Statement

ICU Analyst ratings

ICU Analysis & performance metrics

ICU Company profile

SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically…

SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. The company is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of…

ICU Management team

Name

Position

David A. Green CPA, M.B.A.CFO

Chief Financial Officer

H. David Humes M.D.CEO

Co-Founder and Managing Director

Colonel Kevin Chung FACP, M.D.

Chief Medical Officer

Tim Varacek

Senior Vice President of Commercial & Business Operations

Sai P. Iyer Ph.D.

Senior Vice President of Medical Affairs & Research

Eric SchlorffCEO

Chief Executive Officer, President & Executive Director

Tom Mullen

Vice President of Operations & Product Development

Name

Position

David A. Green CPA, M.B.A.CFO

Chief Financial Officer

H. David Humes M.D.CEO

Co-Founder and Managing Director

Colonel Kevin Chung FACP, M.D.

Chief Medical Officer

Tim Varacek

Senior Vice President of Commercial & Business Operations

Sai P. Iyer Ph.D.

Senior Vice President of Medical Affairs & Research

Eric SchlorffCEO

Chief Executive Officer, President & Executive Director

Tom Mullen

Vice President of Operations & Product Development

Management Team

David A. Green CPA, M.B.A.CFO

Chief Financial Officer

H. David Humes M.D.CEO

Co-Founder and Managing Director

Colonel Kevin Chung FACP, M.D.

Chief Medical Officer

Tim Varacek

Senior Vice President of Commercial & Business Operations

Sai P. Iyer Ph.D.

Senior Vice President of Medical Affairs & Research

Eric SchlorffCEO

Chief Executive Officer, President & Executive Director

Tom Mullen

Vice President of Operations & Product Development

Management

David A. Green CPA, M.B.A.CFO

Chief Financial Officer

H. David Humes M.D.CEO

Co-Founder and Managing Director

Colonel Kevin Chung FACP, M.D.

Chief Medical Officer

Tim Varacek

Senior Vice President of Commercial & Business Operations

Sai P. Iyer Ph.D.

Senior Vice President of Medical Affairs & Research

Eric SchlorffCEO

Chief Executive Officer, President & Executive Director

Tom Mullen

Vice President of Operations & Product Development

Total 7 executives

ICU Frequently asked questions

What is SeaStar Medical Holding Corporation (ICU) Stock Price?

Current stock price of SeaStar Medical Holding Corporation (ICU) stock is $2.880. The stock price is -3.68% lower in the session. The intraday range can be seen from this page. Volume of SeaStar Medical Holding Corporation (ICU) stock is 85.33K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the SeaStar Medical Holding Corporation (ICU) stock price going up or down today?

The stock price of SeaStar Medical Holding Corporation (ICU) can change with earnings, company news, and overall market sentiment. SeaStar Medical Holding Corporation operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the SeaStar Medical Holding Corporation stock expensive at its current price?

Whether SeaStar Medical Holding Corporation looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ICU on this page is -0.91. EPS on this page is -3.18. Compare those figures with peers and growth expectations before deciding if the current SeaStar Medical Holding Corporation price is justified.

How has the stock price of SeaStar Medical Holding Corporation (ICU) performed historically?

Historical performance for SeaStar Medical Holding Corporation (ICU) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ICU reacted to past earnings and market events.

Should I buy SeaStar Medical Holding Corporation (ICU) stock, at this price?

Buying SeaStar Medical Holding Corporation (ICU) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.